PB28 and Prostatic-Neoplasms

PB28 has been researched along with Prostatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for PB28 and Prostatic-Neoplasms

Article	Year
PB183, a sigma receptor ligand, as a potential PET probe for the imaging of prostate adenocarcinoma. Bioorganic & medicinal chemistry letters, 2008, Mar-15, Volume: 18, Issue:6 PB183, a non-selective sigma receptor ligand displaying high sigma-1 and sigma-2 receptor affinity, was evaluated in prostate tumour cell lines for its suitability as PET radiotracer. The pharmacodynamic and pharmacokinetic properties suggested PB183 as a potential PET radiotracer to visualize prostate adenocarcinoma. Topics: Adenocarcinoma; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Chromatography, High Pressure Liquid; Flow Cytometry; Male; Mice; Mice, Transgenic; Molecular Structure; Naphthalenes; Piperazines; Positron-Emission Tomography; Prostatic Neoplasms; Receptors, sigma; Sigma-1 Receptor	2008

Article

Year

PB183, a sigma receptor ligand, as a potential PET probe for the imaging of prostate adenocarcinoma.

Bioorganic & medicinal chemistry letters, 2008, Mar-15, Volume: 18, Issue:6

PB183, a non-selective sigma receptor ligand displaying high sigma-1 and sigma-2 receptor affinity, was evaluated in prostate tumour cell lines for its suitability as PET radiotracer. The pharmacodynamic and pharmacokinetic properties suggested PB183 as a potential PET radiotracer to visualize prostate adenocarcinoma.

Topics: Adenocarcinoma; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Chromatography, High Pressure Liquid; Flow Cytometry; Male; Mice; Mice, Transgenic; Molecular Structure; Naphthalenes; Piperazines; Positron-Emission Tomography; Prostatic Neoplasms; Receptors, sigma; Sigma-1 Receptor

2008